2 Materials and methods 2.1 Study design This study was a multi-center, prospective, double-blind, randomized clinical trial aimed to assess the absorption rate and hence bioavailibility of an innovative oral Sucrosomial B12 (Sidevit B12 developed by Pharmanutra S.p.A, Pisa, Italy) in enhancing circulatory B12 levels in healthy deficient adults, compared to various conventional oral B12 supplement formulations, selected randomly from local pharmacies at each participating center
Data Availability Data will be shared with researchers who submit a research proposal approved by an independent review board
(2022) Matching chemical properties to molecular biological activities opens a new perspective on l-ergothioneine
Weight & Miscarriage (02:37:38) Tools: Supplements
In vitro studies demonstrate that retatrutide exhibits balanced agonistic activity at GCGR and GLP-1R, with comparatively enhanced efficacy at GIPR [119]
Prefer a daily oral supplement over weekly injections